Stay updated with breaking news from Preclinical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr. Anath Shalev, renowned diabetes researcher and Chief Scientific Officer of TIXiMED, Inc., a company dedicated to the development and commercialization of TXNIP inhibiting medications, presented her work on verapamil and TXNIP inhibition at the 2023 Immunology of Diabetes Society Congress in Paris.BIRMINGHAM, Ala...
Collectively referred to as the "Transaction"). The Transaction constituted a reverse takeover of the Company by FTP under applicable securities laws. FTP became a...
Novartis has agreed to divest its front of eye ophthalmology assets to global health company Bausch + Lomb in a $2.5 billion deal, including $1.
The Drug Discovery Outsourcing Market demand is expected to grow at a stable CAGR of 7.2% between 2023 and 2033. The market is expected to surpass a market share of US$ 7.52 billion by 2033, from a value of US$ 3.75 billion in 2023.The pharmaceutical industry’s expansion, as well as the increased penetration of dig...
Dublin, June 20, 2023 (GLOBE NEWSWIRE) -- The "Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report 2023 - 2030" report has been...